echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Eating Tripterygium wilfordii at night is better for rheumatoid arthritis

    Eating Tripterygium wilfordii at night is better for rheumatoid arthritis

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tripterygium wilfordii polyglycoside tablets are clinically one of the most commonly used botanical preparations for the treatment of rheumatoid arthritis (RA).


    A total of 60 patients with refractory RA were included in the study, and they were randomly divided into tripterygium wilfordii polyglycosides 8:00+MTX group and tripterygium wilfordii polyglycosides 20:00+MTX group, with 30 cases in each group


    After 12 weeks of treatment, the 20:00+MTX group of Tripterygium wilfordii polyglycoside tablets based on 28 joint disease activity index (DAS28-ESR) improvement rate was 90.


    The results suggest that the 20:00 administration of tripterygium wilfordii polyglycosides combined with MTX is better than the 8:00 administration of tripterygium wilfordii polyglycosides combined with MTX treatment in the treatment of refractory RA, and the incidence of adverse reactions is low


    References: Wang Zhiqiang, Gong Caixia, Zhang Xiaogang, Ma Xu, Zhang Mingming, Liu Yanqing, Li Zhenbin.


    Tripterygium wilfordii polyglycoside tablets are clinically one of the most commonly used botanical preparations for the treatment of rheumatoid arthritis (RA).


    The efficacy of tripterygium wilfordii polyglycoside tablets combined with MTX treatment at 20: 00 is better than that of tripterygium wilfordii polyglycoside tablets combined with MTX treatment at 8:00 for treatment of refractory RA


    A total of 60 patients with refractory RA were included in the study, and they were randomly divided into tripterygium wilfordii polyglycosides 8:00+MTX group and tripterygium wilfordii polyglycosides 20:00+MTX group, with 30 cases in each group


    After 12 weeks of treatment, the 20:00+MTX group of Tripterygium wilfordii polyglycoside tablets based on 28 joint disease activity index (DAS28-ESR) improvement rate was 90.


    The results suggest that the 20:00 administration of tripterygium wilfordii polyglycosides combined with MTX is better than the 8:00 administration of tripterygium wilfordii polyglycosides combined with MTX treatment in the treatment of refractory RA, and the incidence of adverse reactions is low


    The efficacy of tripterygium wilfordii polyglycoside tablets administered at 20:00 combined with MTX is better than that of tripterygium wilfordii polyglycoside tablets administered at 8:00 combined with MTX treatment, and the incidence of adverse reactions is low


    References: Wang Zhiqiang, Gong Caixia, Zhang Xiaogang, Ma Xu, Zhang Mingming, Liu Yanqing, Li Zhenbin.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.